Overview

A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

Status:
Not yet recruiting

Trial end date:
2023-05-12

Target enrollment:

Participant gender:

Summary

The main goal of this study is to evaluate the efficacy of roxadustat for treatment of anemia in participants with non-myeloid malignancies receiving multi-cycle treatments of myelosuppressive chemotherapy.

Phase:

Phase 3

Details

Lead Sponsor:

FibroGen

Treatments:

Epoetin Alfa